Pro-Active DLBCL Patient Toolkit
May 2022
Find Your Voice.
Being a pro-active diffuse large b-cell lymphoma (DLBCL) patient or caregiver can be overwhelming. The Pro-Active DLBCL Patient Toolkit provides actionable advice and downloadable resources to help you communicate clearly and effectively with your healthcare team.
Programs topics include:
Personalize Your Experience!
Create an account to save items and receive information curated just for you.
Understanding DLBCL
Understanding High-Risk DLBCL
December 7, 2022
What Do Patients Need to Know About DLBCL and COVID Vaccines?
October 28, 2022
A DLBCL Expert Debunks Common Patient Misconceptions
October 28, 2022
What You Should Know About DLBCL Treatment Side Effects
October 28, 2022
What Are Common Symptoms of DLBCL?
October 28, 2022
What Are Common Side Effects of DLBCL Treatment?
October 7, 2022
Who Are the Members of Your DLBCL Care Team?
May 4, 2022
What Are the Stages of DLBCL?
October 25, 2021
Essential Testing Following a DLBCL Diagnosis
October 21, 2021
Understanding Diffuse Large B-cell Lymphoma (DLBCL) and Its Subtypes
October 21, 2021
What Are the Subtypes of DLBCL?
October 14, 2021
What Is Diffuse Large B-cell Lymphoma (DLBCL)?
July 21, 2021
DLBCL Treatment Approaches
Treating Relapsed/Refractory DLBCL
December 7, 2022
How to Make an Informed DLBCL Treatment Decision
December 7, 2022
Emerging DLBCL Treatments That Patients Should Know About
October 28, 2022
Is My DLBCL Treatment Working? What Happens If It Doesn’t Work?
October 28, 2022
Understanding DLBCL Treatment Classes
October 28, 2022
What Should Patients Know About DLBCL Treatment and Research?
September 27, 2022
Which Emerging DLBCL Therapies Are Showing Promise?
May 11, 2022
How Is Relapsed/Refractory DLBCL Treated?
May 11, 2022
How Is DLBCL Treatment Effectiveness Monitored?
May 11, 2022
Which Factors Impact DLBCL Treatment Decisions?
May 11, 2022
How Is DLBCL Treated?
May 11, 2022
Emerging DLBCL Treatment Approaches
May 5, 2022
How Can You Access DLBCL Clinical Trials?
May 5, 2022
An Expert Overview of DLBCL Treatment Approaches
May 5, 2022
Understanding Your DLBCL Treatment Goals
May 4, 2022
An Overview of Current DLBCL Treatment Approaches
October 25, 2021
Should DLBCL Treatment Begin Immediately?
October 25, 2021
How Does Biomarker Testing Impact DLBCL Treatment Options?
October 25, 2021
What Are the Goals of DLBCL Treatment?
October 21, 2021
An Expert Review of DLBCL Research and Treatment Advances
October 14, 2021
Relapsed DLBCL Treatment: What Are the Options?
October 14, 2021
Factors That Guide a DLBCL Treatment Decision
October 14, 2021
How Does Your DLBCL Subtype Impact Your Treatment Options?
October 14, 2021
DLBCL Treatment Decisions: What’s Right for You?
October 5, 2021
How Is Diffuse Large B-Cell Lymphoma (DLBCL) Treated?
July 21, 2021
Tips for DLBCL Patient Self-Advocacy
Why Should DLBCL Patients Engage in Their Care?
December 7, 2022
What Is the Patient’s Role in Their DLBCL Care?
October 28, 2022
Why Should You Consider Seeing a DLBCL Specialist?
October 7, 2022
Advice for Speaking Up About Your DLBCL Care
May 5, 2022
The Benefits of Having a Role in Your DLBCL Treatment Decisions
October 25, 2021
Key Steps Following a DLBCL Diagnosis
October 14, 2021
Should DLBCL Patients Consider a Second Opinion?
July 21, 2021
Expert Advice for Newly Diagnosed DLBCL Patients
July 21, 2021
Planning Your DLBCL Doctor’s Office Visit
DLBCL Care Partner Follow-Up Office Visit Planner
July 22, 2021
DLBCL Care Partner First Office Visit Planner
July 22, 2021
DLBCL Patient Follow-Up Office Visit Planner
July 22, 2021
DLBCL Patient First Office Visit Planner
July 22, 2021
Pro-Active DLBCL Patient Resources
DLBCL Care Partner Shared Decision-Making Planner
December 15, 2022
DLBCL Shared Decision-Making Planner
December 15, 2022
DLBCL Treatment Decision Tree
December 13, 2022
The Pro-Active DLBCL Patient Toolkit 2.0 Resource Guide
December 13, 2022
What Should Patients Know About DLBCL Treatment and Research? Resource Guide
September 27, 2022
The Pro-Active DLBCL Patient Toolkit Resource Guide
October 27, 2021
DLBCL Treatment Decisions: What’s Right For You Resource Guide
October 6, 2021
This program is supported by Bristol Myers Squibb, Incyte, MorphoSys, Pharmacyclics, an AbbVie Company, and through generous donations from people like you.